Find your path to Paul
93 people in our graph share verified history with Paul β schools, employers, funds. One of them is your warm intro.
Catherine Pearce, DHSc, MBAunlockedPaul: together at Merck (1999β2002)
Γ10Paul: together at Merck
Paul: together at Cidara Therapeutics
Executive at Cidara Therapeutics
Intro paths
β
In turn, Paul can intro founders to Cidara Therapeutics's investors below.
Cidara Therapeutics's investors Β· 8
5AM VenturesBoston Β· $100K β $4M checks Β· since 2015Aisling CapitalNew YorkBain Capital Life SciencesBostonCanaan PartnersStamford Β· $500K β $20M checks Β· since 2015Frazier Life SciencesPalo Alto Β· since 2015RA CapitalBostonVenrock Healthcare Capital PartnersNew YorkVivo CapitalPalo Alto Β· $10M β $50M checks
Co-founders at Cidara Therapeutics
JS

Jeffrey SteinExecutive Officer, Director
KJ

Kevin JudiceDirector
Experience
- Biotechnology Executive, Fractional CxO, Consultant and Advisorcurrent2024 β presentSan Diego, CA
- Cellics Therapeutics, Inc.President & CEO at Cellics Therapeutics2022 β 2024San Diego, California, United States
- Cidara TherapeuticsChief Operating Officer2018 β 2022Greater San Diego Area
- Cidara TherapeuticsChief Commercial Officer2014 β 2018Greater San Diego Area
- Delta Sage Consulting, LLC.Founder and Principal2012 β 2022United States
- Bristol-Myers SquibbVice President of US Marketing - Hepatology Franchise2012 β 2014New Jersey
- Vertex PharmaceuticalsVice President Commercial & Strategic Management2010 β 2012Greater Boston Area
- MerckGlobal New Products Leader - Antivirals2007 β 2010
- MerckGlobal Brand Leader - Cancidas2005 β 2007
- MerckDirector of New Product Licensing and Business Development2003 β 2005
- MerckAssociate Director of Marketing - Analgesic & Anti-inflammatory Franchise2001 β 2004Whitehouse Station, NJ
- MerckWorldwide Business Strategy Team Facilitator2001 β 2003NJ and PA
- MerckDistrict Sales Manager1998 β 2000Southeast, US
- MerckManager - Managed Care/Payor Program Manager1996 β 1998West Point, PA
- MerckSpecialist - Medical Team Member - National Service Center1995 β 1996West Point, PA
- MerckSales Representative1992 β 1995Southeast US
Skills & more
Partner Relationship ManagementEntrepreneurshipCoachingPublic SpeakingPresentation DevelopmentOut-licensingPortfolio PlanningGeneric and Brand NamingRisk AssessmentNegotiationGrant PreparationPublic-private Partnerships
+12 more
Academic CollaborationsProduct NamingVendor ManagementOrganizational CultureCulture ChangeAlliance ManagementPortfolio ManagementInvestor RelationsConsumer MarketingChange ManagementTeam BuildingP&L ManagementLanguages English Β· Italian Β· Spanish
From Paul's professional profile.
Frequently asked questions
- Who is Paul Daruwala?
- Executive Officer at Cidara Therapeutics
- Where does Paul Daruwala work?
- Paul Daruwala is Executive at Cidara Therapeutics.
- Where did Paul Daruwala go to school?
- Paul Daruwala studied at University of Kentucky College of Pharmacy (BS, Pharmacy).
Shared employers
Also worked at Cidara Therapeutics4
Also worked at Bristol-Myers Squibb156
Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners
+ 150 more
Also worked at Vertex Pharmaceuticals60
Bruce SachsInvestor at CRV (Charles River Ventures)Jesper GromadaInvestor at Third Rock VenturesStephen ChambersGeneral Partner at SOSVAlexandra CantleyManaging Partner at Polaris PartnersRoger TungVenture Partner at Longwood FundLloyd CarneyStrategic Advisor at Vertical Venture Partners
+ 54 more
Also worked at Merck260
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures
+ 254 more


























